BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 27129161)

  • 1. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 3. PAX8 expression in ovarian surface epithelial cells.
    Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
    Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium.
    Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR
    J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.
    Karthikeyan S; Lantvit DD; Chae DH; Burdette JE
    Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
    Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE
    Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome.
    Salvi A; Hardy LR; Heath KN; Watry S; Pergande MR; Cologna SM; Burdette JE
    Neoplasia; 2023 Feb; 36():100866. PubMed ID: 36586182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
    Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
    Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubal origin of 'ovarian' low-grade serous carcinoma.
    Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
    Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
    Banet N; Kurman RJ
    Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
    Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
    J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
    Auersperg N
    Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
    Wu NY; Huang HS; Chao TH; Chou HM; Fang C; Qin CZ; Lin CY; Chu TY; Zhou HH
    Cell Rep; 2017 Mar; 18(11):2557-2565. PubMed ID: 28297660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.